The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
Open accessAbstract
On 10 January 2020, a new coronavirus causing a pneumonia outbreak in Wuhan City in central China was denoted as 2019-nCoV by the World Health Organization (WHO). As of 24 January 2020, there were 887 confirmed cases of 2019-nCoV infection, including 26 deaths, reported in China and other countries. Therefore, combating this new virus and stopping the epidemic is a matter of urgency. Here, we focus on advances in research and development of fast diagnosis methods, as well as potential prophylactics and therapeutics to prevent or treat 2019-nCoV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle
Lu, H., Stratton, C. W., & Tang, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25678 · Cited by 3,504
Chan, J. F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K. K.-W., Yuan, S., & Yuen, K.-Y. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1719902 · Cited by 3,059
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., et al. (2013) · Nature · doi:10.1038/nature12005 · Cited by 2,061
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Yuan, Y., Cao, D., Zhang, Y., Ma, J., Qi, J., Wang, Q., Lu, G., Wu, Y., Yan, J., Shi, Y., et al. (2017) · Nature Communications · doi:10.1038/ncomms15092 · Cited by 760
Traggiai, E., Becker, S., Subbarao, K., Kolesnikova, L., Uematsu, Y., Gismondo, M. R., Murphy, B. R., Rappuoli, R., & Lanzavecchia, A. (2004) · Nature Medicine · doi:10.1038/nm1080 · Cited by 697
Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction
Corman, V. M., Eckerle, I., Bleicker, T., Zaki, A., Landt, O., Eschbach-Bludau, M., van Boheemen, S., Gopal, R., Ballhause, M., Bestebroer, T. M., et al. (2012) · Eurosurveillance · doi:10.2807/ese.17.39.20285-en · Cited by 561
Jiang, S., Lin, K., Strick, N., & Neurath, A. R. (1993) · Nature · doi:10.1038/365113a0 · Cited by 508
Self-citationLiu, S., Xiao, G., Chen, Y., He, Y., Niu, J., Escalante, C. R., Xiong, H., Farmar, J., Debnath, A. K., Tien, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15788-7 · Cited by 505
Self-citationA pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Xia, S., Yan, L., Xu, W., Agrawal, A. S., Algaissi, A., Tseng, C.-T. K., Wang, Q., Du, L., Tan, W., Wilson, I. A., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav4580 · Cited by 501
Self-citationOmrani, A. S., Saad, M. M., Baig, K., Bahloul, A., Abdul-Matin, M., Alaidaroos, A. Y., Almakhlafi, G. A., Albarrak, M. M., Memish, Z. A., & Albarrak, A. M. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70920-x · Cited by 493
He, Y., Zhou, Y., Liu, S., Kou, Z., Li, W., Farzan, M., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.09.106 · Cited by 403
Self-citationT-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV
Liu, W. J., Zhao, M., Liu, K., Xu, K., Wong, G., Tan, W., & Gao, G. F. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2016.11.006 · Cited by 395
Mehand, M. S., Al-Shorbaji, F., Millett, P., & Murgue, B. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.09.009 · Cited by 389
Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor
Lu, L., Liu, Q., Zhu, Y., Chan, K.-H., Qin, L., Li, Y., Wang, Q., Chan, J. F.-W., Du, L., Yu, F., et al. (2014) · Nature Communications · doi:10.1038/ncomms4067 · Cited by 388
Self-citationBuchholz, U. J., Bukreyev, A., Yang, L., Lamirande, E. W., Murphy, B. R., Subbarao, K., & Collins, P. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403492101 · Cited by 385
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Chan, J. F. W., Chan, K.-H., Kao, R. Y. T., To, K. K. W., Zheng, B.-J., Li, C. P. Y., Li, P. T. W., Dai, J., Mok, F. K. Y., Chen, H., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.09.029 · Cited by 385
Interferon Alfacon-1 Plus Corticosteroids in Severe Acute Respiratory Syndrome: A Preliminary Study
Loutfy, M. R., Blatt, L. M., Siminovitch, K. A., Ward, S., Wolff, B., Lho, H., Pham, D. H., Deif, H., LaMere, E. A., Chang, M., et al. (2003) · JAMA · doi:10.1001/jama.290.24.3222 · Cited by 381
Teengam, P., Siangproh, W., Tuantranont, A., Vilaivan, T., Chailapakul, O., & Henry, C. S. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b00255 · Cited by 347
Jiang, S., Du, L., & Shi, Z. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1723441 · Cited by 330
Self-citationModjarrad, K., Roberts, C. C., Mills, K. T., Castellano, A. R., Paolino, K., Muthumani, K., Reuschel, E. L., Robb, M. L., Racine, T., Oh, M.-D., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30266-x · Cited by 307
Agrawal, A. S., Tao, X., Algaissi, A., Garron, T., Narayanan, K., Peng, B.-H., Couch, R. B., & Tseng, C.-T. K. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1177688 · Cited by 274
Martin, J. E., Louder, M. K., Holman, L. A., Gordon, I. J., Enama, M. E., Larkin, B. D., Andrews, C. A., Vogel, L., Koup, R. A., Roederer, M., et al. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.09.026 · Cited by 267
He, Y., Lu, H., Siddiqui, P., Zhou, Y., & Jiang, S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4908 · Cited by 241
Self-citationTang, X.-C., Agnihothram, S. S., Jiao, Y., Stanhope, J., Graham, R. L., Peterson, E. C., Avnir, Y., Tallarico, A. S. C., Sheehan, J., Zhu, Q., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402074111 · Cited by 232 · cited 1×
“A similar approach is known as single chain fragment variable (scFv) library screening, whereby the use of RBD as a bait protein allows some neutralizing antibodies to be screened out from non-immune humans [72,73].”
Pascal, K. E., Coleman, C. M., Mujica, A. O., Kamat, V., Badithe, A., Fairhurst, J., Hunt, C., Strein, J., Berrebi, A., Sisk, J. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510830112 · Cited by 217
Corti, D., Zhao, J., Pedotti, M., Simonelli, L., Agnihothram, S., Fett, C., Fernandez-Rodriguez, B., Foglierini, M., Agatic, G., Vanzetta, F., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510199112 · Cited by 216
Dyall, J., Gross, R., Kindrachuk, J., Johnson, R. F., Olinger, G. G., Hensley, L. E., Frieman, M. B., & Jahrling, P. B. (2017) · Drugs · doi:10.1007/s40265-017-0830-1 · Cited by 199
Wang, L., Shi, W., Chappell, J. D., Joyce, M. G., Zhang, Y., Kanekiyo, M., Becker, M. M., van Doremalen, N., Fischer, R., Wang, N., et al. (2018) · Journal of Virology · doi:10.1128/jvi.02002-17 · Cited by 169
Bakker, A. B. H., Marissen, W. E., Kramer, R. A., Papaneri, A. B., Weldon, W. C., Niezgoda, M., Hanlon, C. A., Thijsse, S., Backus, H. H. J., de Kruif, J., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.9062-9068.2005 · Cited by 166
Chan, K.-H., Chan, J. F.-W., Tse, H., Chen, H., Lau, C. C.-Y., Cai, J.-P., Tsang, A. K.-L., Xiao, X., To, K. K.-W., Lau, S. K.-P., et al. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.03.015 · Cited by 160
Current advancements and potential strategies in the development of MERS-CoV vaccines
Zhang, N., Jiang, S., & Du, L. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.912134 · Cited by 158
Self-citationA Rapid and Specific Assay for the Detection of MERS-CoV
Huang, P., Wang, H., Cao, Z., Jin, H., Chi, H., Zhao, J., Yu, B., Yan, F., Hu, X., Wu, F., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01101 · Cited by 156
Pacing a small cage: mutation and RNA viruses
Belshaw, R. D., Gardner, A., Rambaut, A., & Pybus, O. G. (2008) · Trends in Ecology & Evolution · doi:10.1016/j.tree.2007.11.010 · Cited by 155
Shirato, K., Yano, T., Senba, S., Akachi, S., Kobayashi, T., Nishinaka, T., Notomi, T., & Matsuyama, S. (2014) · Virology Journal · doi:10.1186/1743-422x-11-139 · Cited by 153
Volz, A., Kupke, A., Song, F., Jany, S., Fux, R., Shams-Eldin, H., Schmidt, J., Becker, C., Eickmann, M., Becker, S., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00614-15 · Cited by 151
Zhao, G., Du, L., Ma, C., Li, Y., Li, L., Poon, V. K., Wang, L., Yu, F., Zheng, B.-J., Jiang, S., et al. (2013) · Virology Journal · doi:10.1186/1743-422x-10-266 · Cited by 144
Self-citationAdvances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain
Zhou, Y., Yang, Y., Huang, J., Jiang, S., & Du, L. (2019) · Viruses · doi:10.3390/v11010060 · Cited by 143
Self-citationHe, Y., Zhou, Y., Siddiqui, P., & Jiang, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.052 · Cited by 130
Self-citationLee, S. H., Baek, Y. H., Kim, Y.-H., Choi, Y. K., Song, M., & Ahn, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02166 · Cited by 121
Olsen, C. W. (1993) · Veterinary Microbiology · doi:10.1016/0378-1135(93)90126-r · Cited by 119
Fett, C., DeDiego, M. L., Regla-Nava, J. Á., Enjuanes, L., & Perlman, S. M. (2013) · Journal of Virology · doi:10.1128/jvi.00087-13 · Cited by 118
Chen, W., Du, L., Chag, S., Ma, C., Tricoche, N., Tao, X., Seid, C. A., Hudspeth, E. M., Lustigman, S., Tseng, C.-T. K., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27464 · Cited by 118
Self-citationHe, Y., Li, J., Li, W., Lustigman, S., Farzan, M., & Jiang, S. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.10.6085 · Cited by 118
Self-citationHe, Y., Zhu, Q., Liu, S., Zhou, Y., Baoan, Y., Li, J., & Jiang, S. (2005) · Virology · doi:10.1016/j.virol.2005.01.034 · Cited by 102
Self-citationWahed, A. A. E., Patel, P., Heidenreich, D., Hufert, F. T., & Weidmann, M. (2013) · PLoS Currents · doi:10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364 · Cited by 97
Aburizaiza, A. S., Mattes, F. M., Azhar, E. I., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit589 · Cited by 95
Munster, V. J., Wells, D., Lambe, T., Wright, D., Fischer, R. J., Bushmaker, T., Saturday, G. A., van Doremalen, N., Gilbert, S. C., de Wit, E., et al. (2017) · npj Vaccines · doi:10.1038/s41541-017-0029-1 · Cited by 89
Specific serology for emerging human coronaviruses by protein microarray
Reusken, C. B. E. M., Mou, H., Godeke, G.-J., van der Hoek, L., Meyer, B., Müller, M. A., Haagmans, B. L., de Sousa, R., Schuurman, N., Dittmer, U., et al. (2013) · Eurosurveillance · doi:10.2807/1560-7917.es2013.18.14.20441 · Cited by 89
Noh, J. Y., Yoon, S., Kim, D., Lee, M., Kim, J. H., Na, W., Song, D., Jeong, D. G., & Kim, H. K. (2017) · Archives of Virology · doi:10.1007/s00705-017-3281-9 · Cited by 88
Antibodies and vaccines against Middle East respiratory syndrome coronavirus
Xu, J., Jia, W., Wang, P., Zhang, S., Shi, X., Wang, X., & Zhang, L. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1624482 · Cited by 88
Coughlin, M. M., & Prabhakar, B. S. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.706 · Cited by 87
Sui, J., Aird, D. R., Tamin, A., Murakami, A., Yan, M., Yammanuru, A., Jing, H., Kan, B., Liu, X., Zhu, Q. K., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000197 · Cited by 82
Chen, Z., Bao, L., Chen, C., Zou, T., Xue, Y., Li, F., Lv, Q., Gu, S., Gao, X., Cui, S., et al. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jix209 · Cited by 78
The impact of pre-existing immunity on the non-clinical pharmacodynamics of AAV5-based gene therapy
Long, B. R., Sandza, K., Holcomb, J., Crockett, L., Hayes, G. M., Arens, J., Fonck, C., Tsuruda, L. S., Schweighardt, B., O’Neill, C. A., et al. (2019) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2019.03.006 · Cited by 75 · cited 1×
“Fourth, pre-existing immunity may eliminate the vaccine by removing the general human virus vectors [47].”
Lokugamage, K. G., Iwata‐Yoshikawa, N., Ito, N., Watts, D. M., Wyde, P. R., Wang, N., Newman, P. C., Tseng, C.-T. K., Peters, C. J., & Makino, S. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.11.092 · Cited by 73
Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections
Gross, A. E., & Bryson, M. L. (2015) · Annals of Pharmacotherapy · doi:10.1177/1060028015597449 · Cited by 60
Chi, H., Zheng, X., Wang, X., Wang, C., Wang, H., Gai, W., Perlman, S. M., Yang, S., Zhao, J., & Xia, X. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.02.063 · Cited by 59
Qiu, H., Sun, S., He, X., Feng, J., Guo, Y., Tai, W., Wang, Y., Du, L., Zhao, G., & Zhou, Y. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.06.003 · Cited by 54
Self-citationXiu, L., Zhang, C., Wú, Z., & Peng, J. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01510 · Cited by 48
Middle East respiratory syndrome: current status and future prospects for vaccine development
Du, L., & Jiang, S. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1092518 · Cited by 43
Self-citationCross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses
Zeng, L., Ge, X., Peng, C., Tai, W., Jiang, S., Du, L., & Shi, Z. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9189-3 · Cited by 39
Self-citationGo, Y. Y., Ys, K., Cheon, S., Nam, S., Ku, K. B., Kim, M., Cho, N., Park, H., Lee, P.-Y. A., Lin, Y.-C., et al. (2017) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2017.06.007 · Cited by 37
Du, L., Ma, C., & Jiang, S. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.05.002 · Cited by 24
Self-citationKoo, B., Hong, K. H., Jin, C. E., Kim, J. Y., Kim, S., & Shin, Y. M. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.08.007 · Cited by 21
Hashemzadeh, M. S., Rasouli, R., Zahraei, B., Izadi, M., Tat, M., Saadat, S. H., Najarasl, M., nejad, B. K., & Dorostkar, R. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.23874 · Cited by 20
Cited by
Guo (2020) · doi:10.1186/s40779-020-00240-0 · Cited by 4,735
Li, Y., Bai, W., & Hashikawa, T. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25728 · Cited by 2,266
A first case of meningitis/encephalitis associated with SARS-Coronavirus-2
Moriguchi, T., Harii, N., Goto, J., Harada, D., Sugawara, H., Takamino, J., Ueno, M., Sakata, H., Kondo, K., Myose, N., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.062 · Cited by 2,024
Coronavirus Disease 2019–COVID-19
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla-Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,876
Wang, Y., Wang, Y., Chen, Y., & Qin, Q. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25748 · Cited by 1,531
Metadata
- Authors
- Yu, F., Du, L., Ojcius, D. M., Pan, C., & Jiang, S.
- Venue
- Microbes and Infection
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 22
- Issue
- 2
- Pages
- 74-79
- ISSN
- 1286-4579 (ISSN-L)
- OpenAlex
- W3003191692
- Cited by
- 366
- References
- 69
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.